Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.
Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe study has been updated to version v2.10.0, indicating a new revision from the previous version v2.9.7.SummaryDifference0.5%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check67 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check73 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a clinical trial for patients with previously-treated advanced non-small cell lung cancer. The update likely includes modifications or additions to the study protocol, outcomes, or other relevant information.SummaryDifference0.1%
Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.